Stocktoria

COMPUGEN LTD CGEN

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2000-08-01

COMPUGEN LTD statistics & valuation

Market cap$197.6M
P / E5.6×
P / S2.7×
P / B1.9×
P / FCF6.3×
Net margin48.6%
Return on equity34.4%
FCF margin43.1%
Return on capital23.4%
Graham number +21.9%$3.05

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($3.05); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-4425.00% -127.00% -1484.90% -570.00% -449.30% -56.10% -51.10% 48.60% 2016201720182019202020212022202320242025
Gross margin (%)
68.70% 94.20% 97.00% 88.70% 87.00% 94.00% 71.50% 87.30% 2016201720182019202020212022202320242025
Operating margin (%)
-4576.30% -130.50% -1574.80% -584.60% -471.70% -38.80% -53.40% 43.10% 2016201720182019202020212022202320242025
Return on equity (%)
-49.60% -126.50% -60.70% -71.30% -24.80% -32.10% -43.40% -28.60% -25.90% 34.40% 2016201720182019202020212022202320242025
Shares outstanding
51.1M 51.3M 59.8M 67.9M 83.7M 86.4M 86.6M 89.2M 89.5M 94.6M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-44.30% -95.70% -42.50% -50.80% -21.50% -25.90% -35.80% -15.50% -12.40% 22.60% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-3148.60% -75.60% -1424.30% -383.00% -461.20% -107.80% 177.60% 43.10% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.62 -$0.72 -$0.41 -$0.43 -$0.37 -$0.41 -$0.39 -$0.21 -$0.16 $0.38 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin87.3%71.5%94.0%87.0%88.7%97.0%—94.2%—68.7%
Operating margin43.1%-53.4%-38.8%-471.7%-584.6%-1574.8%—-130.5%—-4576.3%
Net margin48.6%-51.1%-56.1%-449.3%-570.0%-1484.9%—-127.0%—-4425.0%
FCF margin43.1%177.6%-107.8%-461.2%-383.0%-1424.3%—-75.6%—-3148.6%
Return on assets22.6%-12.4%-15.5%-35.8%-25.9%-21.5%-50.8%-42.5%-95.7%-44.3%
Return on equity34.4%-25.9%-28.6%-43.4%-32.1%-24.8%-71.3%-60.7%-126.5%-49.6%
Current ratio6.565.264.367.237.2112.276.604.665.0313.22

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.